Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Tong Ren Tang Technologies Co ( (HK:1666) ).
Tong Ren Tang Technologies Co. Ltd. has announced an Extraordinary General Meeting (EGM) scheduled for December 30, 2025, to approve key agreements and appointments. The company seeks shareholder approval for the renewal of its Distribution Framework Agreement and Master Procurement Agreement with China Beijing Tong Ren Tang Group Co., Ltd., which will govern connected transactions from 2026 to 2028. Additionally, the appointment of Ms. Du Xin as a non-executive director is on the agenda, reflecting the company’s ongoing efforts to strengthen its governance and operational framework.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine products, with a focus on leveraging its historical brand and extensive market reach in China and abroad.
Average Trading Volume: 1,198,362
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.05B
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.